(ACV) AllianzGI Diversified - Overview
Fund: Equity, Convertible, Income, Allocation
Dividends
| Dividend Yield | 9.40% |
| Yield on Cost 5y | 12.66% |
| Yield CAGR 5y | -27.46% |
| Payout Consistency | 91.3% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 16.2% |
| Relative Tail Risk | 0.69% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.31 |
| Alpha | 17.34 |
| Character TTM | |
|---|---|
| Beta | 0.749 |
| Beta Downside | 0.927 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.46% |
| CAGR/Max DD | 0.78 |
Description: ACV AllianzGI Diversified December 31, 2025
AllianzGI Diversified Income & Convertible Fund (NYSE: ACV) is a U.S.-based open-ended fund that blends fixed-income, convertible securities and equity exposure, targeting an allocation of roughly 30 %–50 % to equities. The fund’s hybrid style aims to capture upside from equity markets while mitigating downside risk through credit and convertible holdings.
Key performance drivers to watch include: (1) the fund’s 30-day SEC yield, which recently hovered around 4.2 %-a useful gauge of income generation in a rising-rate environment; (2) its net asset value (NAV) growth, which has averaged about 6 % annualized over the past three years, reflecting both income and capital appreciation; and (3) the credit quality of its convertible bond portfolio, currently weighted toward investment-grade issuers, which buffers performance when equity volatility spikes. Macro-level factors such as the Federal Reserve’s policy trajectory, equity market volatility (VIX), and corporate earnings trends are especially material for ACV’s mixed-asset approach.
If you want a deeper, data-driven look at how ACV’s risk-adjusted returns compare to peers, a quick check on ValueRay’s analytics dashboard can provide the quantitative context you need.
What is the price of ACV shares?
Over the past week, the price has changed by -2.01%, over one month by +2.27%, over three months by +8.15% and over the past year by +30.99%.
Is ACV a buy, sell or hold?
What are the forecasts/targets for the ACV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 32.6 | 19.4% |
ACV Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 252.8m USD (252.8m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 252.8m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 252.8m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.67% (E(252.8m)/V(252.8m) * Re(8.67%) + (debt-free company))
Discount Rate = 8.67% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)